ArticlePharmaceutical medicine2021
Evaluating the Effectiveness of Apixaban Additional Risk Minimisation Measures Using Surveys in Europe.
Steve Mayall et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it